Skip to main content

Table 1 Demographic data of patients who underwent emergent pancreaticoduodenectomy for non-traumatic etiologies in our series

From: The impact of preoperative etiology on emergent pancreaticoduodenectomy for non-traumatic patients

Sex/age/indication Cancer Procedure/blood loss (ml) APACHE II score/BMI/Hb (g/dL)/albumin (g/dL) Complication/grading Death Hospital stay (days)
M/70/internal bleeding after partial pancreatectomy No CW/1000 17/18.6/13.6/4.9 Bile leakage/2 No 109
M/49/bleeding duodenal lymphoma Lymphoma CW/20 16/20.1/11/2.2 P-duct leakage with Peritonitis/3 No 54
F/78/A-loop perforation after ERCP GC CW/400 12/21.3/9.4/3.3 MOF/4 Yesa 16
F/58/A-loop obstruction and perforation No CW/500 6/17.3/11.9/3.2 Retro-peritoneal infection/3 No 17
M/32/bowel ischemia No CW/2850 19/24.3/11.3/1.9 Septic shock with liver and renal failure/5 Yes 11
F/39/duodenal ulcer bleeding No CW/1000 17/19.5/4.5/2.2 Wound infection/2 No 40
53.5   750 16.5/19.8/11.2/2.7    28.5
  1. ERCP endoscopic retrograde cholangiopancreaticography, GC gastric cancer, CW classic Whipple’s operation, BMI body mass index, MOF multi-organ failure
  2. aThe patient had been discharged and died of complications of MOF 8 months after initial EPD